Medivation prostate cancer drug impresses in pre-chemo study
(Reuters) - Medivation Inc's drug for advanced prostate cancer significantly delayed progression of the disease and extended survival in a large, late...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/GDLAk1Ykypw/story01.htm
No comments:
Post a Comment